Terumo (4543) Stock Overview
Engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 4543 from our risk checks.
4543 Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Terumo Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,922.00 |
| 52 Week High | JP¥2,818.00 |
| 52 Week Low | JP¥1,900.00 |
| Beta | 0.18 |
| 1 Month Change | -12.12% |
| 3 Month Change | -4.40% |
| 1 Year Change | -29.30% |
| 3 Year Change | -7.46% |
| 5 Year Change | -6.79% |
| Change since IPO | 1,518.53% |
Recent News & Updates
Narrative Update • May 15
4543: Fair Valuation And New Development Center Will Support Future Outlook
Analysts have reduced their price target on Terumo from ¥2,300 to ¥2,100. This reflects updated views on fair value, discount rate, revenue growth, profit margins and future P/E assumptions.
Narrative Update • May 01
4543: Offshore Development Center Partnership Will Support Long Term Upside
Terumo’s analyst price target is unchanged at ¥3,700. Analysts point to slightly higher assumed revenue growth and a modestly higher P/E multiple, partly offset by a slightly lower profit margin and higher discount rate in their refreshed models.
Narrative Update • Apr 16
4543: AI Partnerships Will Support Future Earnings And Dividend Expansion
Analysts have nudged their Terumo price target slightly lower to ¥2,872 from ¥2,918, reflecting updated views on discount rates, revenue growth assumptions, profit margins, and future P/E levels. What's in the News Terumo is holding an Analyst and Investor Day to share more detail on its mid to long term growth drivers, giving you more visibility into how management frames the business over time.Recent updates
Narrative Update • May 15
4543: Fair Valuation And New Development Center Will Support Future Outlook
Analysts have reduced their price target on Terumo from ¥2,300 to ¥2,100. This reflects updated views on fair value, discount rate, revenue growth, profit margins and future P/E assumptions.Narrative Update • May 01
4543: Offshore Development Center Partnership Will Support Long Term Upside
Terumo’s analyst price target is unchanged at ¥3,700. Analysts point to slightly higher assumed revenue growth and a modestly higher P/E multiple, partly offset by a slightly lower profit margin and higher discount rate in their refreshed models.Narrative Update • Apr 16
4543: AI Partnerships Will Support Future Earnings And Dividend Expansion
Analysts have nudged their Terumo price target slightly lower to ¥2,872 from ¥2,918, reflecting updated views on discount rates, revenue growth assumptions, profit margins, and future P/E levels. What's in the News Terumo is holding an Analyst and Investor Day to share more detail on its mid to long term growth drivers, giving you more visibility into how management frames the business over time.Narrative Update • Apr 02
4543: Higher Profit Margins And New Development Center Will Support Long Term Upside
Analysts are maintaining their price target for Terumo at ¥3,700. This reflects only minor updates to assumptions, including a slightly lower discount rate, a modestly different revenue growth outlook, and a small adjustment to expected profit margins and future P/E levels.Narrative Update • Mar 19
4543: US Imaging Advances Will Support Future Earnings And Dividend Expansion
Analysts have slightly revised their price target for Terumo to reflect a fair value estimate of ¥2,917.69, compared with the prior ¥2,956.15. They cited modest adjustments to the discount rate and forward P/E assumptions while keeping revenue growth and profit margin expectations broadly unchanged.Narrative Update • Mar 05
4543: US Imaging Advances Will Support Future Earnings And Dividend Expansion
Analysts have adjusted their price target for Terumo from ¥3,136 to ¥2,956. This change reflects updated assumptions around fair value, discount rate, revenue growth, profit margins and future P/E expectations.Narrative Update • Feb 19
4543: Higher Profit Margins And Stable Discount Rate Will Support Long Term Upside
Analysts have kept their fair value estimate for Terumo steady at ¥3,700.00, citing slightly higher discount rate assumptions, a modest adjustment to revenue growth expectations, and a small uplift in projected profit margins and future P/E as the key drivers behind the unchanged price target. Valuation Changes Fair Value: Kept unchanged at ¥3,700.00, indicating no adjustment to the overall valuation anchor.Narrative Update • Feb 04
4543: Higher Dividends And Resilient Margins Will Support Positive Outlook
Analysts have revised their price target for Terumo to ¥2,300 from ¥2,500, citing adjustments to fair value assumptions, discount rate, revenue growth, profit margin, and expected future P/E levels. What's in the News Second quarter dividend for the period ending in 2026 set at ¥15.00 per share, compared with ¥13.00 per share a year earlier (company guidance).Analysis Article • Jan 27
These 4 Measures Indicate That Terumo (TSE:4543) Is Using Debt Safely
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Jan 21
4543: Dividend Increases And Imaging Approval Will Support Long Term Upside
Analysts have trimmed their price target on Terumo from ¥3,900 to ¥3,700. This reflects updated assumptions around a slightly higher discount rate, adjusted profit margins, a higher revenue growth outlook, and a lower future P/E multiple.Narrative Update • Jan 07
4543: Dividend Increases And U.S. Device Adoption Will Support Balanced Outlook
Analysts have kept their price target for Terumo steady at ¥2,500, citing only minor model tweaks in the discount rate, revenue growth, profit margin and future P/E assumptions, rather than a material change in their view of the shares. What's in the News Terumo announced a second quarter dividend for the period ending in 2026 of ¥15.00 per share, with payment scheduled for December 2, 2025.Analysis Article • Dec 31
Returns At Terumo (TSE:4543) Are On The Way Up
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Narrative Update • Dec 19
4543: Dividend Stability And U.S. Imaging Expansion Will Support Balanced Outlook
Analysts have modestly reduced their price target on Terumo from ¥2,550 to ¥2,500, citing a slightly higher discount rate, despite improved expectations for revenue growth, profit margins, and a lower future price to earnings multiple. What's in the News Announced a higher second quarter 2026 dividend of JPY 15.00 per share, up from JPY 13.00 a year earlier, and guided to maintain JPY 15.00 per share for the full fiscal year ending March 31, 2026 (company guidance).Analysis Article • Dec 18
Terumo (TSE:4543) Will Pay A Dividend Of ¥15.00
Terumo Corporation ( TSE:4543 ) has announced that it will pay a dividend of ¥15.00 per share on the 25th of June. This...Analysis Article • Dec 17
The Price Is Right For Terumo Corporation (TSE:4543)
When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Terumo...Narrative Update • Dec 05
4543: US Imaging Advances Will Support Earnings And Dividend Expansion
Analysts have modestly trimmed their price target on Terumo by approximately ¥44 to reflect slightly lower projected profit margins, partially offset by a small uptick in expected revenue growth and a marginally reduced discount rate. What's in the News Revised full year 2026 guidance now assumes higher revenue of JPY 1,108,000 million but lower operating profit of JPY 181,500 million and EPS of JPY 92.20.Analysis Article • Dec 03
Terumo's (TSE:4543) Dividend Will Be ¥15.00
The board of Terumo Corporation ( TSE:4543 ) has announced that it will pay a dividend on the 25th of June, with...Narrative Update • Nov 21
4543: US Imaging System Launch Will Drive Earnings Momentum Forward
Narrative Update on Terumo Analysts have lowered their price target for Terumo from ¥3,293 to ¥3,181. This reflects adjustments to profit margin estimates and an increase in the assumed discount rate, even as projected revenue growth has been revised upwards.Analysis Article • Nov 20
We Think Terumo's (TSE:4543) Healthy Earnings Might Be Conservative
The stock was sluggish on the back of Terumo Corporation's ( TSE:4543 ) recent earnings report. Along with the solid...Analysis Article • Nov 14
Terumo Corporation (TSE:4543) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?
Last week, you might have seen that Terumo Corporation ( TSE:4543 ) released its half-yearly result to the market. The...Narrative Update • Nov 05
4543: US Imaging Debut And Board Actions Will Support Earnings Strength Ahead
Analysts have slightly raised their fair value estimate for Terumo from ¥3,288.57 to ¥3,293.57, citing modest adjustments to the discount rate and future expectations for earnings growth. What's in the News Terumo Interventional Systems has received FDA 510(k) clearance for its OPUSWAVE Dual Sensor Imaging System and DualView imaging catheter, marking the company’s imaging debut in the US market (Key Developments).Narrative Update • Oct 22
Analysts Lift Terumo Price Target as Profit Margin Outlook Improves Amid Board Developments
Narrative Update on Terumo: Analyst Price Target Change Analysts have modestly increased their price target for Terumo from ¥3,239 to ¥3,289. This change reflects higher profit margin estimates and ongoing confidence in the company's performance, despite minor adjustments to growth and valuation metrics.Analysis Article • Oct 08
Here's Why We Think Terumo (TSE:4543) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Sep 22
Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Terumo Corporation's ( TSE:4543 ) dividend will be increasing from last year's payment of the same period to ¥15.00 on...Analysis Article • Sep 08
Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
The board of Terumo Corporation ( TSE:4543 ) has announced that it will be paying its dividend of ¥15.00 on the 3rd of...Narrative Update • Sep 05
US And China Health Trends Will Create Lasting Market Impact
With both Terumo’s discount rate and future P/E ratio remaining effectively unchanged, the consensus analyst price target has been maintained at ¥3239. What's in the News Board meeting held to consider and approve disposal of treasury shares as Restricted Stock remuneration.Analysis Article • Aug 25
Terumo (TSE:4543) Has Announced That It Will Be Increasing Its Dividend To ¥15.00
Terumo Corporation ( TSE:4543 ) has announced that it will be increasing its dividend from last year's comparable...Analysis Article • Aug 10
Terumo Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Investors in Terumo Corporation ( TSE:4543 ) had a good week, as its shares rose 6.7% to close at JP¥2,736 following...Analysis Article • Aug 07
Why Investors Shouldn't Be Surprised By Terumo Corporation's (TSE:4543) P/E
TSE:4543 1 Year Share Price vs Fair Value Explore Terumo's Fair Values from the Community and select yours With a...Analysis Article • Jul 25
Terumo (TSE:4543) Is Increasing Its Dividend To ¥15.00
Terumo Corporation ( TSE:4543 ) has announced that it will be increasing its dividend from last year's comparable...Analysis Article • Jul 24
Terumo (TSE:4543) Seems To Use Debt Rather Sparingly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analysis Article • Jul 11
Terumo's (TSE:4543) Upcoming Dividend Will Be Larger Than Last Year's
Terumo Corporation ( TSE:4543 ) will increase its dividend from last year's comparable payment on the 3rd of December...Analysis Article • Jul 09
Here's Why We Think Terumo (TSE:4543) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Analysis Article • Jun 21
Terumo (TSE:4543) Has More To Do To Multiply In Value Going Forward
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Analysis Article • May 21
We Like The Quality Of Terumo's (TSE:4543) Earnings
The market seemed underwhelmed by last week's earnings announcement from Terumo Corporation ( TSE:4543 ) despite the...Analysis Article • May 18
Earnings Miss: Terumo Corporation Missed EPS By 9.8% And Analysts Are Revising Their Forecasts
Terumo Corporation ( TSE:4543 ) shareholders are probably feeling a little disappointed, since its shares fell 2.1% to...
New Narrative • Nov 10
Tactical Innovation And Global Expansion Set The Stage For Impressive Growth
Terumo's innovation and new market creation focus, including entering the venous intervention market, aim to drive future sales and revenue growth.Shareholder Returns
| 4543 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -2.6% | 1.8% | 0.6% |
| 1Y | -29.3% | 12.3% | 40.0% |
Return vs Industry: 4543 underperformed the JP Medical Equipment industry which returned 12.2% over the past year.
Return vs Market: 4543 underperformed the JP Market which returned 40.9% over the past year.
Price Volatility
| 4543 volatility | |
|---|---|
| 4543 Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in JP Market | 9.7% |
| 10% least volatile stocks in JP Market | 2.4% |
Stable Share Price: 4543 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4543's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1921 | n/a | Hikaru Samejima | www.terumo.com |
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others.
Terumo Corporation Fundamentals Summary
| 4543 fundamental statistics | |
|---|---|
| Market cap | JP¥2.84t |
| Earnings (TTM) | JP¥127.90b |
| Revenue (TTM) | JP¥1.10t |
22.2x
P/E Ratio2.6x
P/S RatioIs 4543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4543 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.10t |
| Cost of Revenue | JP¥511.31b |
| Gross Profit | JP¥584.19b |
| Other Expenses | JP¥456.28b |
| Earnings | JP¥127.90b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 86.71 |
| Gross Margin | 53.33% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 26.3% |
How did 4543 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield32%
Payout RatioDoes 4543 pay a reliable dividends?
See 4543 dividend history and benchmarks| Terumo dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 25 2026 |
| Days until Ex dividend | 48 days |
| Days until Dividend pay date | 39 days |
Does 4543 pay a reliable dividends?
See 4543 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/15 16:26 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Terumo Corporation is covered by 27 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Liu | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Ritsuo Watanabe | BofA Global Research |